U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT03761797) titled 'A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes' on Nov. 30, 2018.

Brief Summary: Study objectives is to investigate the safety of long-term daily use of TRADIANCE(R) Combination Tablets AP and BP in Japanese patients with Type 2 Diabetes mellitus (T2DM) used in routine care.

Study Type: Observational

Condition: Diabetes Mellitus, Type 2

Intervention: * Drug: TRADIANCE(R) Combination Tablets AP

Fixed dose combination

* Drug: TRADIANCE(R) Combination Tablets BP

Fixed dose combination

Recruitment Status: Recruiting

Sponsor: Boehringer Ingelheim

Information provided by (Responsible ...